Correspondence 0001477932-24-007272 from CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)

CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.
Date: Nov. 15, 2024 · CIK: 0001187953 · Accession: 0001477932-24-007272

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-283091

Date

November 15, 2024

Author

/s/ Timothy Warbington

Form

CORRESP

Company

CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.

Letter

Via Edgar Division of Corporation Finance Office of Life Sciences Registration Statement on Form S-1 Filed November 8, 2024 File No. 333-283091 Request for Acceleration

Dear Mr. Gorsky:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Creative Medical Technology Holdings, Inc. (the “Company”), hereby requests acceleration of the effective date of the above-referenced Registration Statement to 4:00 p.m. on Tuesday, November 19, 2024, or as soon thereafter as practicable.

Please contact Zev M. Bomrind of Pachulski Stang Ziehl & Jones LLP, counsel to the Company, at (646) 483-5497, as soon as the registration statement has been declared effective, or if you have any other questions or concerns regarding this matter.

Sincerely,
/s/ Timothy Warbington

Show Raw Text

CORRESP
1
filename1.htm

celz_corresp.htm

 November 15, 2024

 Via Edgar

 Mr. Joshua Gorsky

 Division of Corporation Finance

 Office of Life Sciences

 U.S. Securities and Exchange Commission

 Washington, D.C. 20549

   Re:

  Creative Medical Technology Holdings, Inc.

  Registration Statement on Form S-1

  Filed November 8, 2024

  File No. 333-283091

  Request for Acceleration

 Dear Mr. Gorsky:

 Pursuant to Rule 461 under the Securities Act of 1933, as amended, Creative Medical Technology Holdings, Inc. (the “Company”), hereby requests acceleration of the effective date of the above-referenced Registration Statement to 4:00 p.m. on Tuesday, November 19, 2024, or as soon thereafter as practicable.

 Please contact Zev M. Bomrind of Pachulski Stang Ziehl & Jones LLP, counsel to the Company, at (646) 483-5497, as soon as the registration statement has been declared effective, or if you have any other questions or concerns regarding this matter.

   Sincerely,

      /s/ Timothy Warbington

  Timothy Warbington

        Chief Executive Officer

SecProbe.io